Ranbaxy Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?
RANBAXY has forty-five approved drugs.
There are fifteen tentative approvals on RANBAXY drugs.
Summary for Ranbaxy
US Patents: | 0 |
Tradenames: | 33 |
Ingredients: | 29 |
NDAs: | 45 |
PTAB Cases with Ranbaxy as petitioner: | See PTAB cases with Ranbaxy as petitioner |
Drugs and US Patents for Ranbaxy
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ranbaxy | AVENTYL | nortriptyline hydrochloride | SOLUTION;ORAL | 014685-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ranbaxy Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 076220-003 | Sep 2, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ranbaxy Labs Ltd | LORATADINE | loratadine | SYRUP;ORAL | 076529-001 | Aug 20, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ranbaxy
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ranbaxy | AVENTYL | nortriptyline hydrochloride | SOLUTION;ORAL | 014685-001 | Approved Prior to Jan 1, 1982 | 3,922,305 | ⤷ Sign Up |
Ranbaxy | RIOMET | metformin hydrochloride | SOLUTION;ORAL | 021591-001 | Sep 11, 2003 | 6,890,957 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.